
15 August 2025
ISSUE OF OPTIONS
DIRECTOR/PDMR HOLDINGS
Celsius Resources Limited (Celsius or CLA) (ASX, AIM:CLA) has issued 9,375,000 options over new ordinary shares exercisable at $0.01 each and expiring on 20 May 2028, to Paul Dudley and Mark van Kerkwijk (the "Options"). 4,687,500 Options have been issued to Paul Dudley and 4,687,500 Options have been issued to Mark van Kerkwijk.
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||
a) | Name |
Van Kerkwijk Family Superannuation Pty Ltd
| ||||||
2 | Reason for the notification | |||||||
a) | Position/status | Director/PDMR | ||||||
b) | Initial notification /Amendment | Initial Notification | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | Celsius Resources Limited | ||||||
b) | LEI | 529900017SKWCWGSVH68 | ||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument Identification code | - Listed options exercisable at $0.01 each and expiring on 20 May 2028 AU000000CLA6 | ||||||
| Nature of the transaction | Issue of Options as approved by shareholders on 7 August 2025. | ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information
|
| ||||||
e) | Date of the transaction | 14 August 2025 | ||||||
f) | Place of the transaction | Off market |
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||
a) | Name |
Paul Dudley | ||||||
2 | Reason for the notification | |||||||
a) | Position/status | Director/PDMR | ||||||
b) | Initial notification /Amendment | Initial Notification | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | Celsius Resources Limited | ||||||
b) | LEI | 529900017SKWCWGSVH68 | ||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument Identification code | - Listed options exercisable at $0.01 each and expiring on 20 May 2028 AU000000CLA6 | ||||||
| Nature of the transaction | Issue of Options as approved by shareholders on 7 August 2025. | ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information
|
| ||||||
e) | Date of the transaction | 14 August 2025 | ||||||
f) | Place of the transaction | Off market |
This announcement has been authorised by the Board of Directors of Celsius Resources Limited.
For further information contact:
|
|
| ||
Celsius Resources Limited Neil Grimes | P: +61 8 9324 4516 |
| ||
Multiplier Media (Australia Media Contact) Jon Cuthbert |
M: +61 402 075 707 E: jon.cuthbert@multiplier.com.au
|
| ||
Zeus Capital Limited (Nominated Adviser & Broker) Harry Ansell/James Joyce/James Bavister
|
P: +44 (0) 20 3 829 5000 | |||
Zeus Capital Limited ("Zeus") is the Company's Nominated Adviser and is authorised and regulated by FCA. Zeus's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Zeus is not acting for and will not be responsible to any persons for providing protections afforded to customers of Zeus nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.